Results 61 to 70 of about 192,372 (174)
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax : a randomized controlled trial [PDF]
BACKGROUND: Intermittent preventive treatment in infants (IPTi) has been shown in randomized trials to reduce malaria-related morbidity in African infants living in areas of high Plasmodium falciparum (Pf) transmission. It remains unclear whether IPTi is
Reeder, J. C. +102 more
core +1 more source
Applied genomics: data mining reveals species-specific malaria diagnostic targets more sensitive than 18S rRNA. [PDF]
Accurate and rapid diagnosis of malaria infections is crucial for implementing species-appropriate treatment and saving lives. Molecular diagnostic tools are the most accurate and sensitive method of detecting Plasmodium, differentiating between ...
Jenna Oberstaller +27 more
core +1 more source
ABSTRACT Background The safety of pharmacological treatments during pregnancy is a significant concern, as many medications lack comprehensive reproductive safety data. This creates gaps in therapeutic options for pregnant women, particularly malaria, which poses serious risks to maternal and fetal health.
Wookyung Kim +9 more
wiley +1 more source
Background: Malaria continues to be a major public health problem in India. Vivax malaria is being increasingly seen with thrombocytopenia. The reported prevalence of the same has been extremely variable and its significance is not well established. This
Sudhir Sudhakar Khune +2 more
doaj +1 more source
ABSTRACT Plasmodium vivax (P. vivax) malaria, once regarded as a comparatively benign infection, is increasingly recognized as a cause of severe, potentially life‐threatening multisystem disease. Concurrent secondary hemophagocytic lymphohistiocytosis (HLH), disseminated intravascular coagulation (DIC), and acute pancreatitis complicating P.
Tasnim Nafian +5 more
wiley +1 more source
Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India
The mounting evidence supporting the capacity of Plasmodium vivax to cause severe disease has prompted the need for a better characterization of the resulting clinical complications. India is making progress with reducing malaria, but epidemics of severe
Anupkumar R. Anvikar +11 more
doaj +1 more source
Plasmodium vivax liver stage assay platforms using Indian clinical isolates
Background Vivax malaria is associated with significant morbidity and economic loss, and constitutes the bulk of malaria cases in large parts of Asia and South America as well as recent case reports in Africa.
Pradeep A. Subramani +19 more
doaj +1 more source
Malaria vaccine research and development: the role of the WHO MALVAC committee. [PDF]
The WHO Malaria Vaccine Advisory Committee (MALVAC) provides advice to WHO on strategic priorities, activities and technical issues related to global efforts to develop vaccines against malaria.
Vasee S Moorthy +9 more
core +1 more source
ABSTRACT Background and Aims Malaria remains a major global health concern, causing substantial morbidity and mortality, especially in tropical and subtropical regions with limited healthcare resources. Climatic conditions and extreme weather events are increasingly recognized as critical determinants of malaria transmission, yet their relative ...
Md. Abu Bokkor Shiddik +1 more
wiley +1 more source
A case of congenital
In February 2011, a rare case of congenital Plasmodium vivax malaria was diagnosed in a temperate region of Central China. An infant developed intermittent fever 20 days after delivery.
Liu Xue +7 more
doaj +1 more source

